Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 324 participants.

Also called NCT05856851

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 324 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05856851
Other papers using this trial's data
  • Intra-Arterial Alteplase After Successful Endovascular Reperfusion in Patients Without Intravenous Thrombolysis: A Subgroup Analysis of the PEARL Randomized Clinical Trial Journal of the American Heart Association, 2026-11-03 DOI, PubMed 42924842

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05856851. Randomized; single masking; primary purpose treatment. Start 2023-08-01 (actual); primary completion 2025-01-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy
Acronym
PEARL
Condition
Stroke, Acute Ischemic
Intervention (Drug)
Alteplase
Lead sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (class: other)
Collaborator
Shenzhen Hospital of Southern Medical University (class: other)

Record details

Record id
cardio:ct-nct05856851
Content hash
e039431e18b6b17da5a4502bedba876e8133eab70aa449a8b40659de4fea4a6f